is glp 1 good for perimenopause GLP-1 Microdosing and Menopause: A Hormone-Aware Metabolic Framework HRT + GLP-1 for Perimenopause

is contracted via the University of Liverpool (no personal payment) to undertake consultancy for Altimmune, AstraZeneca, Boehringer Ingelheim, Cytoki, Eli Lilly, Napp, Novo Nordisk, Menarini, Pfizer, Rhythm Pharmaceuticals, Sanofi, Saniona, Tern, Shionogi and Ysopia and declares personal honoraria/lecture fees from AstraZeneca, Boehringer Ingelheim, Medscape, Menarini, Napp, Novo Nordisk and Rhythm

A supervised program will say no when the clinical picture requires it

Conclusion Despite the substantial obstacles to getting bench findings to the patient, numerous scientists are still working towards this goal

This indirect approach produces modest insulin release and typically causes minimal weight loss, distinguishing it from direct GLP-1 agonist therapy

The National Institutes of Health, which helped fund this fundamental research, had declared a moratorium on recombinant DNA research in warm-blooded animals as scientists evaluated ethical and safety concerns of the new technology

doi: 10.1111/jcpt.13225 225 GardnerHHamdyO